Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAF(V600)- mutated melanoma (BRIM7)

Guardat en:
Dades bibliogràfiques
Autors principals: Puzanov, Igor, McArthur, Grant, Gonzalez, Rene, Pavlick, Anna, Hamid, Omid, Gajewski, Thomas F, Yin, Ming, Fredrickson, Jill, Choong, Nicholas, Ribas, Antoni
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Oral Presentation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4126212/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-12-S1-O7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars